QS Investors LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 2.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 80,272 shares of the company’s stock after purchasing an additional 1,577 shares during the period. QS Investors LLC’s holdings in Colgate-Palmolive were worth $6,057,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Jacobi Capital Management LLC raised its holdings in Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. Virtue Capital Management LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth about $104,000. Krilogy Financial LLC raised its holdings in Colgate-Palmolive by 23.0% during the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Captrust Financial Advisors purchased a new position in Colgate-Palmolive during the second quarter worth about $122,000. Finally, Bruderman Asset Management LLC purchased a new position in Colgate-Palmolive during the second quarter worth about $126,000. 73.87% of the stock is owned by hedge funds and other institutional investors.
CL has been the subject of several analyst reports. BNP Paribas cut shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target for the company. Citigroup upped their target price on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 30th. Finally, KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $77.91.
Colgate-Palmolive (NYSE CL) opened at $70.87 on Wednesday. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 27.02. Colgate-Palmolive has a 1 year low of $68.19 and a 1 year high of $77.91. The firm has a market cap of $62,218.23, a PE ratio of 31.08, a price-to-earnings-growth ratio of 2.63 and a beta of 0.79.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.75 EPS for the quarter, meeting the consensus estimate of $0.75. The business had revenue of $3.89 billion for the quarter, compared to analyst estimates of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.75 earnings per share. equities analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be given a $0.42 dividend. The ex-dividend date is Thursday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 2.37%. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.